Baloxavir Shows Broad Antiviral Activity Against Influenza A, B, C, and DJuly 24th 2019
In the wake of prior findings that influenza A viruses exhibited reduced susceptibility to single-dose baloxavir, a new study indicates that the antiviral medication inhibits all 4 types of flu, including viruses with pandemic potential.
Trial Pairs PrEP With Behavioral Intervention to Prevent HIV in Drug UsersJuly 11th 2019
The program combines PrEP administration along with evidence-based behavioral intervention to reduce HIV risk behavior for HIV-negative, opioid-dependent people who use drugs and are receiving treatment.
Prophylactic Antibiotic Reduces Risk of Infection by 56% Following Operative Vaginal BirthMay 29th 2019
Although antibiotic prophylaxis for new mothers is common following caesarean section births, a new study provides evidence of benefits on infection reduction in women following operative vaginal birth.
2019 Fluoroquinolone Breakpoints Revised for Enterobacteriaceae and Pseudomonas aeruginosaMay 17th 2019
A revision to the fluoroquinolone antimicrobial susceptibility testing breakpoints for 2 bacteria comes following evidence that previous breakpoints were too high to detect low-level antibiotic resistance.